NCT05909150View on ClinicalTrials.gov

Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation

PHASE2RecruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 8, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Heart TransplantationAcute Kidney Injury
Interventions
DRUG

Sodium chloride solution 3,5%

Patients will receive 150 mL HSS 3,5% intravenous twice daily for 3 days after heart transplantation.

DRUG

Sodium chloride solution 0,9%

Patients will receive 150 mL NS 0,9% intravenous twice daily for 3 days after heart transplantation.

Trial Locations (1)

Unknown

RECRUITING

Heart Institute, University of São Paulo., São Paulo

All Listed Sponsors
lead

Fernando Bacal

OTHER